Why would mescaline in a cactus, psilocybin in a mushroom, and DMT in a jungle vine all activate the same receptor in the human brain? The answer may lie not in coincidence but in convergent evolutionary pressure — and the implications for understanding both plant defense chemistry and psychedelic-assisted therapy are profound.
A study published in PNAS examines how phenethylamines, indolealkylamines, and terpenoid-scaffold compounds arose independently across plants, fungi, and animals yet consistently converge on conserved serotonergic neural targets — particularly the 5-HT2A receptor. The analysis maps the ecological origins of these compounds as defensive chemicals, produced to deter herbivores or microbial threats, and traces how their structural diversity masks a shared pharmacological endgame. The research highlights that chemical convergence at the receptor level is not accidental but reflects deep evolutionary conservation of the target architecture itself, making it a recurring biochemical vulnerability exploitable by unrelated organisms across hundreds of millions of years.
This framing recontextualizes a question that psychedelic medicine has largely sidestepped: why do these structurally dissimilar molecules produce functionally overlapping effects in humans? The convergent evolution argument suggests the 5-HT2A receptor's conformational binding pocket is unusually stable across evolutionary time, making it susceptible to chemical mimicry from wildly different biosynthetic pathways. For longevity and brain-health researchers, this carries practical weight — the robustness of the target implies therapeutic compounds need not be structurally identical to be clinically effective, potentially broadening the design space for next-generation psychoplastogens. A key limitation is that PNAS reviews of this nature synthesize existing literature rather than generate new experimental data, so causal claims about ecological selection pressure remain inferential. Still, this is a genuinely paradigm-clarifying synthesis that repositions hallucinogens from cultural curiosities into subjects of rigorous evolutionary biology.